Simplified Issue vs Accelerated Issue: Technology Differences Explained
Simplified issue vs accelerated issue technology--how the underwriting paths differ, where they're converging, and what carriers should know in 2026.

The line between simplified issue and accelerated issue life insurance keeps getting blurrier. Five years ago, the two sat in clearly separate corners of the underwriting world. Simplified issue meant fewer questions, higher premiums, and limited face amounts--a product designed for speed at the cost of precision. Accelerated issue meant a technology-driven triage that routed healthy applicants past the paramedical exam while keeping fully underwritten rates intact. In 2026, the technology stacks powering these two pathways are starting to overlap in ways that matter for carriers, actuaries, and reinsurers trying to figure out where to invest.
"The distinction between accelerated underwriting and simplified issue is beginning to narrow. SI products are now adopting tools that have historically been more closely associated with AU, including more robust applications and new scoring tools." --RGA Knowledge Center, 2025
What Actually Separates These Two Pathways
The core difference has always been about risk tolerance and pricing. Simplified issue accepts less information and charges more for the uncertainty. Accelerated issue gathers more data electronically and tries to maintain fully underwritten pricing for qualifying applicants.
But the technology question is where things get interesting. Accelerated underwriting programs typically pull from electronic health records, prescription history databases like MIB and Milliman IntelliScript, motor vehicle records, credit-based insurance scores, and increasingly, real-time biometric data. The underwriting engine scores these inputs through predictive models and either issues a decision or kicks the application to traditional review.
Simplified issue, historically, relied on a short application--sometimes as few as three to five health questions--and little else. The actuarial pricing reflected this: mortality assumptions baked in the cost of anti-selection, and face amounts stayed capped (often at $50,000 to $100,000 for older applicants).
Here's what's changed: simplified issue carriers are now grafting accelerated underwriting technology onto their programs. They're adding prescription checks, MIB hits, and algorithmic scoring to what was once a bare-bones questionnaire process. The SOA's 2020 research report on simplified issue underwriting documented this shift, noting that mortality outcomes in SI programs vary enormously "based on many selection levers," and that "two seemingly similar programs may not result in a similar mortality outcome."
Technology Stack Comparison: Simplified Issue vs Accelerated Issue
| Feature | Traditional Simplified Issue | Modern Simplified Issue | Accelerated Underwriting |
|---|---|---|---|
| Application questions | 3-8 health questions | 8-15 questions with follow-up logic | Full application or near-full |
| Prescription database (Rx) | Rarely used | Increasingly adopted | Standard (IntelliScript, Rx data) |
| MIB check | Sometimes | Usually | Always |
| Electronic health records | No | Emerging (Munich Re/MIB partnership) | Growing adoption post-2025 |
| Credit-based scoring | Rare | Some carriers | Common |
| Motor vehicle records | Rare | Some carriers | Common |
| Predictive models / AI | Minimal | Partial adoption | Central to workflow |
| Real-time biometric data | No | Not yet | Emerging (rPPG, wearables) |
| Paramedical exam | Never | Never | Skipped for qualifying applicants |
| Face amount ceiling | $50K-$250K typical | Expanding to $500K+ | Up to $1M-$3M+ |
| Pricing basis | Loaded for anti-selection | Partially refined | Fully underwritten rates |
| Target cycle time | 24-48 hours | Same day to 48 hours | Minutes to 48 hours |
The gap is closing from both sides. Munich Re and MIB announced a strategic partnership in May 2025 specifically aimed at accelerating electronic health record adoption across life insurance--a data source that was once exclusive to accelerated programs but is now being explored for simplified products too.
Where the Convergence Is Real (and Where It Isn't)
Data Inputs Are Converging
The most obvious change is at the data layer. When a simplified issue program adds prescription history checks and algorithmic scoring, it starts to resemble an accelerated program with a shorter application. RGA's analysis points out that SI products "are now adopting tools that have historically been more closely associated with AU." This is real and measurable. Carriers like Bestow and Ethos have built products that don't fit neatly into either category--they use short applications paired with extensive electronic data pulls and predictive models.
Pricing Philosophy Still Diverges
Even with the data convergence, the pricing math stays different. Accelerated underwriting aims to identify applicants who qualify for standard or preferred rates without fluid verification (we covered this in detail in our piece on what accelerated underwriting actually is). The economic model depends on accurately routing low-risk applicants past the exam. Simplified issue starts from a different assumption: the carrier knows it has less information and prices accordingly. Even with added data sources, most SI programs still carry mortality loadings that accelerated programs don't.
The NAIC's Accelerated Underwriting Working Group has been examining the regulatory implications since 2024, with particular focus on how predictive models and non-traditional data sources affect consumer outcomes. Their draft guidance notes that "accelerated underwriting relies on predictive models or machine learning algorithms that use non-traditional, non-medical data" and flags the potential for unfair discrimination--a concern that applies equally to modernized SI programs using the same tools.
Mortality Experience Tells the Story
The SOA's simplified issue research found that mortality outcomes depend heavily on the specific combination of selection levers a carrier deploys. Key determinants include "application structure, target market, distribution method, individual selection criteria, claims adjudication policies." Two programs that look similar on paper can produce wildly different claims experience.
For accelerated underwriting, Munich Re's retrospective studies have shown that adding electronic health records to claims data measurably improves underwriting outcomes. Their 2025 analysis demonstrated that EHR data captures risk signals that prescription databases and MIB alone miss--particularly for conditions where patients receive diagnosis and treatment within hospital systems rather than through retail pharmacy channels.
The Role of Biometric Data in Both Pathways
Real-time biometric measurement could reshape both SI and AU at the same time, and it's worth paying attention to why. Remote photoplethysmography--capturing heart rate, heart rate variability, and respiratory rate through a smartphone camera--offers an objective physiological data point that doesn't require a lab visit or a wearable device.
For accelerated underwriting, biometric data fills the gap left by eliminating the paramedical exam. Heart rate variability alone carries significant actuarial signal: the UK Biobank study (a collaboration between RGA and the University of Leicester analyzing over 400,000 participants) found that resting heart rate was among the non-traditional factors that "dramatically improved the ability to differentiate mortality and morbidity risks."
For simplified issue, the calculus is different but equally compelling. If a 30-second smartphone scan can provide objective cardiovascular data, carriers could reduce the anti-selection loading in their pricing without adding the friction that defeats the purpose of a simplified product. The marginal cost is near zero. The applicant experience stays fast.
How Biometric Signals Map to Underwriting Decisions
| Biometric Signal | What It Indicates | Relevance to SI | Relevance to AU |
|---|---|---|---|
| Resting heart rate | Cardiovascular fitness, autonomic function | Identifies high-risk applicants in minimal-question programs | Corroborates or flags applicants routed past exam |
| Heart rate variability | Stress, autonomic balance, cardiac risk | Adds objective data to offset questionnaire limitations | Refines risk scoring for borderline cases |
| Blood pressure estimate | Hypertension screening | Could reduce need for follow-up questions | Replaces one component of traditional exam |
| Respiratory rate | Pulmonary health, stress state | Early signal for conditions not captured by Rx checks | Additional data point for comprehensive scoring |
| Oxygen saturation | Respiratory and cardiac function | Screening layer for COPD, sleep apnea | Supports fluidless assessment in higher face amounts |
Companies like Circadify are building this capability for the insurance market--smartphone-based contactless vitals that can integrate directly into digital application flows. For carriers weighing where to put money, the biometric layer is one of the few investments that improves both simplified and accelerated pathways without requiring separate infrastructure for each.
What Carriers Should Actually Be Thinking About
Build for the Merged Future
The carriers that will be best positioned in 2028 are the ones building flexible underwriting platforms now--systems that can dial data requirements up or down based on face amount, applicant age, and risk appetite. A rigid "this is our SI product and this is our AU product" approach is already looking outdated. Gen Re's survey data shows accelerated underwriting reduces cycle time by an average of 18 business days versus full underwriting. The question is whether you can get similar cycle times with better risk selection than traditional SI.
Watch the Regulatory Environment
The NAIC's work on accelerated underwriting governance will affect both pathways. If predictive models using non-traditional data face new disclosure or fairness requirements, those requirements won't distinguish between a model deployed in an SI product versus an AU product. Carriers should be building model governance frameworks that cover their entire digital underwriting portfolio, not product by product.
Reinsurer Expectations Are Shifting
Reinsurers are increasingly evaluating accelerated and simplified programs based on data quality, not just on which label a carrier attaches to the product. Munich Re's Biometric Portfolio Analysis, drawing on 15+ years of data from more than 30 participating insurers, gives reinsurers the tools to assess how specific data inputs affect mortality experience. A simplified issue program with robust electronic data and biometric screening may actually get better reinsurance terms than an accelerated program that relies heavily on questionnaire responses with limited verification.
Current Research and Evidence
Several independent research efforts back up this convergence story:
The SOA's simplified issue underwriting report (2020) remains the most comprehensive analysis of mortality variation across SI programs, documenting how different selection levers produce different outcomes. Their finding that application structure and distribution method matter as much as the data sources themselves is often overlooked.
Munich Re's 2024 Accelerated Underwriting Survey, combined with their 2025 partnership with MIB on electronic health records, represents the strongest industry signal that EHR adoption will extend beyond traditional AU programs. Their retrospective analysis showed that adding EHR to existing data sources improved risk classification in ways that Rx data alone could not achieve.
RGA's analysis of SI and AU convergence provides the clearest framing of where the industry is headed: the two pathways are adopting each other's tools, and the distinction is becoming more about pricing philosophy than technology capability.
The NAIC's Accelerated Underwriting Working Group draft guidance (June 2024) addresses the regulatory dimension, particularly around predictive model governance and fairness in both AU and modernized SI contexts.
The Future of Underwriting Pathways
These two products probably won't merge into one--the pricing and risk tolerance differences are real and serve different market segments. What will happen is the technology stack converges while the product positioning stays distinct.
Simplified issue will remain the faster, lower-friction path for lower face amounts and harder-to-insure populations. But it will increasingly look like accelerated underwriting under the hood, pulling from the same electronic data sources and predictive models. Accelerated underwriting will continue pushing toward higher face amounts and preferred pricing, layering in new data sources like EHRs and real-time biometrics to maintain confidence without fluid verification.
The carriers that do well will be the ones treating underwriting technology as a platform, not a product feature--modular, configurable, and capable of serving both pathways from shared data and decision infrastructure.
Frequently Asked Questions
What is the main difference between simplified issue and accelerated issue life insurance?
Simplified issue uses a shortened application with fewer health questions and limited data verification, charging higher premiums to account for the uncertainty. Accelerated issue uses electronic data sources and predictive models to evaluate risk thoroughly enough to skip the medical exam while maintaining fully underwritten pricing for qualifying applicants.
Are simplified issue and accelerated issue converging?
Yes, at the technology level. Simplified issue programs are increasingly adopting electronic data pulls (prescription histories, MIB checks, credit scoring) that were previously associated with accelerated underwriting. However, the pricing philosophy and target markets remain different.
Which approach produces better mortality experience?
It depends entirely on the specific program design. The SOA's research found that mortality outcomes vary enormously across simplified issue programs based on application structure, target market, and data sources used. Accelerated programs that incorporate EHR data and biometric measurements tend to have stronger risk selection, but a well-designed modern SI program can outperform a poorly designed AU program.
How does contactless biometric screening fit into these pathways?
Contactless biometric screening through technologies like rPPG provides objective physiological data (heart rate, HRV, respiratory rate) from a smartphone camera in under a minute. For simplified issue, it adds a verification layer without adding friction. For accelerated underwriting, it helps replace components of the paramedical exam. Companies like Circadify are building this capability specifically for insurance application workflows.
